JP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | EJN. European journal of neuroscience | 2024 | 76 | 136 | |||
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports. Medicine | 2023 | 265 | 136 | |||
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | 2023 | 136 | 174 | |||
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | 2022 | 251 | 338 | |||
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | 2022 | 103 | 136 | |||
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica | 2021 | 397 | 3 | |||
| Sphingosine‐1‐phosphate as a key player of insulin secretion induced by high‐density lipoprotein treatment | Physiological reports | 2021 | 253 | 142 | |||
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | 2020 | 344 | 795 | |||
| Analogues du GLP-1 en 2019 : pour qui et comment ? | Revue médicale suisse | 2019 | 458 | 1 | |||
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | 2019 | 304 | 133 | |||
| Cellular circadian period length inversely correlates with HbA1c levels in individuals with type 2 diabetes | Diabetologia | 2019 | 520 | 5 | |||
| Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis | Thrombosis Research | 2019 | 353 | 1 | |||
| Validation of molecular biomarkers for preoperative diagnostics of human papillary thyroid carcinoma in fine needle aspirates | Gland Surgery | 2019 | 500 | 5 | |||
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | 2018 | 367 | 171 | |||
| Composite pheochromocytoma with neuroblastoma: a case report | 20th European Congress of Endocrinology | 2018 | 148 | 1 | |||
| Time zones of pancreatic islet metabolism | Diabetes, Obesity and Metabolism | 2018 | 471 | 0 | |||
| Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism | Journal of Clinical Endocrinology and Metabolism | 2018 | 663 | 4 | |||
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | 2018 | 513 | 2 | |||
| Manifestations musculosquelettiques du diabète sucré : une complication fréquente | Revue médicale suisse | 2017 | 367 | 0 | |||
| Anti-CTLA-4 Monoclonal Antibodies Induced Hypophysitis: Case Report and Literature Review | Annals of Clinical Case Reports | 2017 | 450 | 125 | |||
| Traitement du diabète de type 2 : risques et bénéfices de la chirurgie métabolique | Revue médicale suisse | 2017 | 374 | 0 | |||
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | 2017 | 369 | 195 | |||
| Association des analogues du GLP-1 et des inhibiteurs du SGLT2 : de nouvelles perspectives ? | Revue médicale suisse | 2017 | 382 | 0 | |||
| The search for preoperative biomarkers for thyroid carcinoma: application of the thyroid circadian clock properties | Biomarkers in medicine | 2017 | 568 | 1 | |||
| Pancreatic α- and β-cellular clocks have distinct molecular properties and impact on islet hormone secretion and gene expression | Genes and Development | 2017 | 631 | 41 | |||
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | 2017 | 397 | 1 | |||
| Prévention et guérison du diabète : est-ce possible ? | Revue médicale suisse | 2016 | 461 | 0 | |||
| Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma | Oncotarget | 2016 | 673 | 258 | |||
| Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia | Endocrinology | 2016 | 530 | 0 | |||
| Effects of liver transplantation on endocrine function: a systematic review | Liver international | 2016 | 551 | 4 | |||
| α-Cell Dysfunctions and Molecular Alterations in Male Insulinopenic Diabetic Mice Are Not Completely Corrected by Insulin | Endocrinology | 2016 | 614 | 1 | |||
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | 2016 | 419 | 2 | |||
| Dysthyroïdies liées à une surcharge iodée | Revue médicale suisse | 2016 | 394 | 0 | |||
| Insuline et antidiabétiques oraux : comment les associer dans la pratique ambulatoire ? | Revue médicale suisse | 2016 | 505 | 3 | |||
| Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway | Proceedings of the National Academy of Sciences of the United States of America | 2015 | 559 | 263 | |||
| Thyroid Circadian Timing: Roles in Physiology and Thyroid Malignancies | Journal of biological rhythms | 2015 | 689 | 0 | |||
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | 2015 | 559 | 332 | |||
| Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis | Canadian journal of diabetes | 2015 | 543 | 0 | |||
| Acute painful diabetic neuropathy: an uncommon, remittent type of acute distal small fibre neuropathy | Schweizerische medizinische Wochenschrift | 2015 | 595 | 2 | |||
| Erreurs innées du métabolisme: transition enfant-adulte | Revue médicale suisse | 2015 | 615 | 2 | |||
| Statins and Diabetes: The Plot Thickens | Journal of general internal medicine | 2015 | 455 | 0 | |||
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | 2015 | 403 | 1 | |||
| Baisse de la déhydroépiandrostérone avec l'âge : pertinence clinique et intérêt thérapeutique | Revue médicale suisse | 2015 | 566 | 1 | |||
| Restoration of adrenal function after bilateral adrenal damage due to heparin-induced thrombocytopenia (HIT): a case report | Journal of medical case reports | 2015 | 677 | 319 | |||
| Endocrinologie :l'hyperparathyroïdie primaire asymptomatique en 2014 | Revue médicale suisse | 2015 | 502 | 1 | |||
| Identification of new biomarkers for human papillary thyroid carcinoma employing NanoString analysis | Oncotarget | 2015 | 779 | 420 | |||
| Diabétologie | Revue médicale suisse | 2015 | 490 | 0 | |||
| Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabétiques de type 2 obèses | Revue médicale suisse | 2015 | 499 | 1 | |||
| Syndrome des ovaires polykystiques : quoi de neuf ? | Revue médicale suisse | 2015 | 554 | 1 | |||
| Endocrinologie | Revue médicale suisse | 2014 | 549 | 0 | |||
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | 2014 | 489 | 0 | |||
| Le concept de parcours de santé ou la difficile révolution de la prise en charge des maladies chroniques | Revue médicale suisse | 2014 | 474 | 0 | |||
| Foxa1 and Foxa2 regulate α-cell differentiation, glucagon biosynthesis, and secretion | Endocrinology | 2014 | 630 | 0 | |||
| La testostérone : un traitement pour la prévention des maladies cardiovasculaires ? | Revue médicale suisse | 2014 | 500 | 0 | |||
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | 2014 | 573 | 0 | |||
| Quelle insuline pour quel patient en 2014 ? | Revue médicale suisse | 2014 | 457 | 0 | |||
| Glucagon: the renewal of an old hormone in the pathophysiology of diabetes | Journal of diabetes and its complications | 2013 | 591 | 0 | |||
| Autonomous and self-sustained circadian oscillators displayed in human islet cells | Diabetologia | 2013 | 750 | 176 | |||
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | 2013 | 637 | 0 | |||
| Circadian clock characteristics are altered in human thyroid malignant nodules | The Journal of clinical endocrinology and metabolism | 2013 | 750 | 2 | |||
| A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? | Rejuvenation research | 2013 | 768 | 897 | |||
| Implications of somatostatin analogues in the treatment of acromegaly | European endocrinology | 2013 | 367 | 205 | |||
| Hypoglycémie non diabétique : diagnostic et prise en charge | Revue médicale suisse | 2013 | 679 | 2 | |||
| Sport et diabète de type 1 | Revue médicale suisse | 2013 | 672 | 0 | |||
| Biofeedback can reduce foot pressure to a safe level and without causing new at-risk zones in patients with diabetes and peripheral neuropathy | Diabetes/metabolism research and reviews | 2013 | 616 | 1 | |||
| Maladies chroniques : le politique doit s'engager ! | Revue médicale suisse | 2013 | 427 | 1 | |||
| Diabète de la personne âgée : une prise en charge sur mesure | Revue médicale suisse | 2013 | 575 | 0 | |||
| Biological rhythms and preeclampsia | Frontiers in endocrinology | 2013 | 750 | 542 | |||
| Pax6 is a key component of regulated glucagon secretion | Endocrinology | 2012 | 1,051 | 0 | |||
| Sommeil et diabète | Revue médicale suisse | 2012 | 508 | 0 | |||
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | 2012 | 627 | 0 | |||
| Néphropathie diabétique | Revue médicale suisse | 2012 | 659 | 1 | |||
| Hypothermia is a frequent sign of severe hypoglycaemia in patients with diabetes | Diabetes & metabolism | 2012 | 644 | 0 | |||
| Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology | Schweizerische medizinische Wochenschrift | 2012 | 2,020 | 1,318 | |||
| La médecine personnalisée et la face cachée de la lune | Revue médicale suisse | 2012 | 491 | 1 | |||
| Pax6 is crucial for β-cell function, insulin biosynthesis, and glucose-induced insulin secretion | Molecular endocrinology | 2012 | 655 | 0 | |||
| Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion | Diabetes, obesity & metabolism | 2011 | 649 | 0 | |||
| Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin | Endocrine practice | 2011 | 591 | 0 | |||
| Hémoglobine glyquée: nouvel outil de dépistage? | Revue médicale suisse | 2011 | 712 | 1 | |||
| Prise en charge du diabète gestationnel: nouvelles connaissances et perspectives futures | Revue médicale suisse | 2011 | 701 | 1 | |||
| Prise en charge du diabète et réseaux médicaux: est-ce la solution? | Revue médicale suisse | 2011 | 497 | 0 | |||
| Diagnostic et traitement de l'insuffisance pancréatique exocrine lors d'un diabète | Diabetes, Stoffwechsel und Herz | 2011 | 549 | 0 | |||
| Importance de la décharge dans le traitement des lésions du pied diabétique | Revue médicale suisse | 2011 | 558 | 1 | |||
| Multislice gated-computed tomography of cardiac paragangliomas | Journal of the American College of Cardiology | 2010 | 502 | 0 | |||
| Pax6 controls the expression of critical genes involved in pancreatic {alpha} cell differentiation and function | The Journal of biological chemistry | 2010 | 615 | 1 | |||
| Comment minimiser la prise de poids secondaire au traitement d'insuline? | Revue médicale suisse | 2010 | 634 | 0 | |||
| L'aspirine en prévention primaire chez les patients diabétiques | Revue médicale suisse | 2010 | 490 | 0 | |||
| Insuline et cancer: mythe ou realité? | Revue médicale suisse | 2010 | 593 | 0 | |||
| Diabète et cancer: une association pernicieuse | Revue médicale suisse | 2010 | 658 | 0 | |||
| Treating type 2 diabetes: how safe are current therapeutic agents? | International journal of clinical practice | 2009 | 547 | 0 | |||
| Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2 | Molecular and cellular biology | 2009 | 634 | 0 | |||
| Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark | American journal of transplantation | 2009 | 975 | 6 | |||
| Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial | Diabetes, obesity & metabolism | 2008 | 883 | 8 | |||
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | 2008 | 550 | 0 | |||
| Motesanib diphosphate in progressive differentiated thyroid cancer | The New England journal of medicine | 2008 | 545 | 0 | |||
| Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol | American journal of transplantation | 2006 | 906 | 289 | |||
| Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control | American journal of transplantation | 2006 | 891 | 283 | |||
| Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function | The Journal of clinical endocrinology and metabolism | 2005 | 707 | 399 | |||
| The zinc finger-containing transcription factor Gata-4 is expressed in the developing endocrine pancreas and activates glucagon gene expression | Molecular endocrinology | 2005 | 614 | 0 | |||
| Pax2 mutant mice display increased number and size of islets of Langerhans but no change in insulin and glucagon content | European journal of endocrinology | 2004 | 686 | 0 | |||
| Islet autotransplantation for the prevention of surgical diabetes after extended pancreatectomy for the resection of benign tumors of the pancreas | Transplantation proceedings | 2004 | 806 | 0 | |||
| Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations | Transplantation proceedings | 2004 | 798 | 1 | |||
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | 2003 | 637 | 0 | |||
| Islet autotransplantation after left pancreatectomy for non-enucleable insulinoma | American journal of transplantation | 2003 | 857 | 646 | |||
| Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients | Transplantation | 2003 | 757 | 1 | |||
| Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription | Diabetologia | 2003 | 697 | 192 | |||
| Molecular detection of circulating beta-cells after islet transplantation | Diabetes | 2002 | 737 | 369 | |||
| An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events | Diabetologia | 2002 | 488 | 0 | |||
| Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure | Transplantation proceedings | 2002 | 722 | 0 | |||
| Hepatic nuclear factor-3 (HNF-3 or Foxa2) regulates glucagon gene transcription by binding to the G1 and G2 promoter elements | Molecular endocrinology | 2002 | 531 | 0 | |||
| Pdx1 level defines pancreatic gene expression pattern and cell lineage differentiation | The Journal of biological chemistry | 2001 | 658 | 1,657 | |||
| Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation | Transplant international | 2001 | 818 | 0 | |||
| Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations | Transplantation | 2000 | 725 | 0 | |||
| Le traitement du diabète par transplantation: quelles sont les indications | Médecine et hygiène | 2000 | 670 | 0 | |||
| Transplantation d'îlots de Langerhans: Quo vadis? | Médecine et hygiène | 1998 | 673 | 0 | |||
| Results of human islet allotransplantation in cystic fibrosis and type I diabetic patients | Transplantation proceedings | 1998 | 753 | 0 | |||
| Ablation of islet endocrine cells by targeted expression of hormone-promoter-driven toxigenes | Proceedings of the National Academy of Sciences of the United States of America | 1994 | 630 | 1 | |||
| Air in the bones: multifocal anaerobic osteomyelitis associated with oat cell carcinoma | BMJ. British medical journal | 1985 | 572 | 0 | |||
| Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats | The Journal of clinical investigation | 1981 | 591 | 0 | |||
| Resistance against subcutaneous insulin successfully managed with aprotinin | Lancet | 1980 | 667 | 0 | |||
| Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor | Biochemical journal | 1979 | 633 | 0 |
